Published in Scand J Immunol on March 01, 1991
Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J Exp Med (1992) 2.22
Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med (1996) 1.49
Characterization of cytokine production in infectious mononucleosis studied at a single-cell level in tonsil and peripheral blood. Clin Exp Immunol (1993) 0.88
IgE antibody production is associated with suppressed interferon-gamma levels in mesenteric lymph nodes of rats infected with the nematode Nippostrongylus brasiliensis. Immunology (1994) 0.85
Pretreatment of lymphocytes with mercury in vitro induces a response in T cells from genetically determined low-responders and a shift of the interleukin profile. Immunology (1997) 0.79
STUDIES OF UREA EXCRETION. III: The Influence of Body Size on Urea Output. J Clin Invest (1928) 45.56
STUDIES OF UREA EXCRETION: VI. Comparison of the Blood Urea Clearance with Certain Other Measures of Renal Function. J Clin Invest (1930) 7.46
Murine CD1d-restricted T cell recognition of cellular lipids. Immunity (2000) 3.57
Studies on antigen-binding cells. I. The origin of reactive cells. Cell Immunol (1970) 2.53
Transplantation of porcine fetal pancreas to diabetic patients. Lancet (1994) 2.52
"Spontaneous" B cell activation due to loss of normal mouse serum suppressor. Eur J Immunol (1972) 2.38
Phase-coupling of theta-gamma EEG rhythms during short-term memory processing. Int J Psychophysiol (2002) 2.09
Transcriptomic and proteomic patterns of systemic inflammation in on-pump and off-pump coronary artery bypass grafting. Circulation (2005) 1.83
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets. J Immunol (1998) 1.77
Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol (1997) 1.73
Xylene-free method for histological preparation: a multicentre evaluation. Lab Invest (2001) 1.70
Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen. Cytokine detection by immunoassay and intracellular immunostaining. J Immunol Methods (1993) 1.60
HLA and rheumatoid arthritis. A study of five families. Tissue Antigens (1981) 1.58
HL-A antigens in sarcoidosis. Tissue Antigens (1973) 1.55
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection. J Virol (1993) 1.48
Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases. Scand J Immunol (1980) 1.46
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Antigen binding cells in tolerant animals. Nature (1970) 1.35
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
Scandiatransplant: preliminary report of a kidney exchange program. Transplant Proc (1971) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
B-cell mitogenic effects on human lymphocytes of rabbit anti-human beta 2-microglobulin. Scand J Immunol (1975) 1.27
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
CD1d-specific NK1.1+ T cells with a transgenic variant TCR. J Immunol (2000) 1.22
Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion (1998) 1.21
HLA-DR-DQ haplotypes defined by restriction fragment analysis. Correlation to serology. Hum Immunol (1987) 1.20
Complete heart block--another HLA B27 associated disease manifestation. Tissue Antigens (1983) 1.16
CD13 (human aminopeptidase N) mediates human cytomegalovirus infection. J Virol (1993) 1.14
B-cell activation of peripheral blood lymphocytes from patients with chronic lymphatic leukaemia. Clin Exp Immunol (1978) 1.14
Cytotoxicity by nonimmune allogeneic lymphoid cells. Specific suppression by antibody treatment of the lymphoid cells. J Exp Med (1967) 1.12
Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol (1986) 1.11
Induction of antibody synthesis in human B lymphocytes by different polyclonal B cell activators: evaluation by direct and indirect PFC assays. Immunol Rev (1979) 1.10
Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions. Semin Immunol (2000) 1.10
CD1high B cells: a population of mixed origin. Eur J Immunol (1999) 1.10
Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand J Immunol (1998) 1.08
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07
B cell differentiation factor in synovial fluid of patients with rheumatoid arthritis. Immunol Rev (1984) 1.07
HLA phenotypes and diabetic retinopathy. Diabetologia (1978) 1.06
HLA haplotypes in families with high frequency of multiple sclerosis. Arch Neurol (1976) 1.04
Effects of some immunosuppressive procedures on myasthenia gravis. Ann N Y Acad Sci (1976) 1.04
Optimal conditions for polyclonal antibody secretion and DNA synthesis in human blood and spleen lymphocytes by lipopolysaccharide. Scand J Immunol (1978) 1.04
Antibody production and DNA synthesis of human lymphocyte subpopulations induced by PPD tuberculin. Clin Exp Immunol (1979) 1.03
The use of bacteria for the functional characterization of human lymphocyte subpopulations in various lymphoid organs. Scand J Immunol (1978) 1.03
HLA-A,B,C and DR antigens in psoriasis. Tissue Antigens (1981) 1.00
Neutropenia and insufficiency of the exocrine pancreas. Acta Paediatr Scand (1967) 1.00
Residual C-peptide excretion is associated with a better long-term glycemic control and slower progress of retinopathy in type I (insulin-dependent) diabetes mellitus. J Diabet Complications (1991) 1.00
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. J Immunol (1985) 0.99
Unilateral, isometric bite force in 8-68-year-old women and men related to occlusal factors. Scand J Dent Res (1990) 0.99
Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. Hum Immunol (1984) 0.97
Antigenic markers on mouse lymphoid cells: the presence of MBLA on antibody forming cells and antigen binding cells. Cell Immunol (1972) 0.96
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
Cytotoxic effects in vitro by lymphoid cells from specifically tolerant animals. Immunology (1969) 0.96
HLA--determination in families with hereditary ataxia. Tissue Antigens (1978) 0.95
Tuberculous meningitis: immune reactions within the central nervous system. Scand J Immunol (1981) 0.95
Expression of CD1d2 on thymocytes is not sufficient for the development of NK T cells in CD1d1-deficient mice. J Immunol (1999) 0.95
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis. Tissue Antigens (1978) 0.94
Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol (1996) 0.94
Antigen-presenting function of the TL antigen and mouse CD1 molecules. Immunol Rev (1995) 0.93
Differential regulation of Ly49 expression on CD4+ and CD4-CD8- (double negative) NK1.1+ T cells. Eur J Immunol (2000) 0.92
Genetic basis of multiple sclerosis: HLA antigens, disease progression, and oligoclonal IgG in CSF. Acta Neurol Scand (1979) 0.92
High incidence of spontaneous Ig-producing lymphocytes in peripheral blood and synovial fluid of patients with active seropositive rheumatoid arthritis. Scand J Immunol (1982) 0.92
Neutralization of human cytomegalovirus by human CD13-specific antibodies. J Infect Dis (1996) 0.91
Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice. Transplantation (1996) 0.91
Characterization of human adenoid cells using surface and functional markers for lymphocyte subpopulations. Clin Exp Immunol (1977) 0.91
Studies on the major histocompatibility system in patients with ankylosing spondylitis. Tissue Antigens (1975) 0.90
Markedly elevated serum IgE levels following allogeneic and syngeneic bone marrow transplantation. Blood (1983) 0.90
Identification of five lymphocyte activating determinants in man. Tissue Antigens (1975) 0.90
Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis. Clin Exp Immunol (1975) 0.90
Adjuvants influence the immunoglobin subclass distribution of immune responses in vivo. Scand J Immunol (1984) 0.89
Considerations of some current concepts in cancer research. J Natl Cancer Inst (1975) 0.89
HLA antigens in selective IgA deficiency: distribution in healthy donors and patients with recurrent respiratory tract infections. Tissue Antigens (1984) 0.89
Antigen-binding cells in immune and tolerant animals. Transplant Rev (1972) 0.87
Psoriasis, sacro-iliitis and peripheral arthritis occurring in patients with the same HLA haplotype. A preliminary family report and a hypothetical explanation of the interaction between MHS products. Tissue Antigens (1976) 0.87
The continuing carrier problem. Transplant Rev (1974) 0.87
A DR4-associated DR-DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum (1988) 0.87
Antigenic markers on mouse lymphoid cells: origin of cells mediating immunologic memory. Cell Immunol (1973) 0.87
Cytokines in rheumatoid arthritis. Ann Med (1991) 0.87
[Immunoglobulin E in allergic bronchial asthma with special reference to the most important inhalation antigens]. Dtsch Med Wochenschr (1972) 0.87
HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations. Tissue Antigens (1979) 0.86
Specificity of hapten-reactive T and B mouse lymphocytes. Affinity and avidity of T- and B-cell receptors and anti-hapten antibodies as factors of dose and time after immunization. Scand J Immunol (1974) 0.86
Follow-up of children of insulin dependent (type I) and gestational diabetic mothers. Growth pattern, glucose tolerance, insulin response, and HLA types. Acta Paediatr Scand (1984) 0.86
Inhibition of the Fc receptor of human lymphoid cells by antisera-recognizing determinants of the hla system. J Exp Med (1976) 0.86
Mitogenic properties of rabbit anti-human beta 2-microglobulin for murine B cells. Scand J Immunol (1974) 0.86
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand J Immunol (2002) 0.85
Presence of alloantigen-reactive cells in neonatally tolerized mice. Scand J Immunol (1978) 0.85
Human NK cell and ADCC reactivity against xenogeneic porcine target cells including fetal porcine islet cells. Xenotransplantation (1998) 0.84
Differences in the ligand specificity between CD1d-restricted T cells with limited and diverse T-cell receptor repertoire. Scand J Immunol (2000) 0.84
In vitro characterization of immunological responsiveness of uremic patients. Nephron (1980) 0.84
Atopy and HLA antigens in patients with keratoconus. Acta Ophthalmol (Copenh) (1982) 0.84
[Treatment of chronic liver diseases with thioctic acid]. Med Klin (1967) 0.83
Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical. Transplantation (1990) 0.83
Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation (2001) 0.83
Optic neuritis and distribution of genetic markers of the HLA systems. Acta Neurol Scand (1978) 0.83
Role of MLC compatibility in intrafamilial kidney transplantation. Transplantation (1976) 0.83
HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med (1988) 0.83
Detection of individual interleukin 4- and gamma interferon-producing murine spleen cells after activation with T-cell mitogens. Scand J Immunol (1989) 0.82